Nevertheless, our study has determined the expression profile and clinical roles of IRF6 in ccRCC through various databases and laboratory experiments, and these findings may provide a theoretical basis for the development of new therapeutic target. The gene discussed is IRF6; the disease is nonpapillary renal cell carcinoma.